MPO and acute coronary syndrome: Recently, no significant differences were found regarding the circulating MPO and MMP-9 levels in 209 CAD patients with OSA compared to the levels in 152 patients without OSA among the participants of the ISAACC (CPAP in Patients with Acute Coronary Syndrome and OSA) trial [30].